• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

同步性腹膜转移结直肠癌患者预后列线图的开发与验证

Development and Validation of a Prognostic Nomogram for Colorectal Cancer Patients With Synchronous Peritoneal Metastasis.

作者信息

Yang Zifeng, Li Yong, Qin Xiusen, Lv Zejian, Wang Huaiming, Wu Deqing, Yuan Zixu, Wang Hui

机构信息

Department of Colorectal Surgery, The Sixth Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China.

Guangdong Institute of Gastroenterology, Guangdong Provincial Key Laboratory of Colorectal and Pelvic Floor Diseases, Supported by National Key Clinical Discipline, The Sixth Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China.

出版信息

Front Oncol. 2021 Jul 1;11:615321. doi: 10.3389/fonc.2021.615321. eCollection 2021.

DOI:10.3389/fonc.2021.615321
PMID:34277396
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8281961/
Abstract

PURPOSE

Synchronous peritoneal metastasis (S-PM) is considered a poor prognostic factor for colorectal cancer (CRC) and there is no nomogram to predict the survival of these patients. In this study, we aimed to use a multicenter data to identify the factors associated with S-PM of CRC to construct a nomogram for predicting the overall survival (OS) of these patients.

METHODS

CRC patients with S-PM from two medical centers were enrolled between September 2007 and June 2017. Multivariate analysis was used to identify independent factors associated with OS for the nomogram to predict the 1-, 2-, and 3-year OS rates in the development group. The concordance index (C-index), calibration plot, relative operating characteristic (ROC) curve with area under the curve (AUC) were calculated to evaluate the performance of the nomogram in both the development and an external validation group.

RESULTS

277 CRC patients with S-PM in the development group and 68 patients in the validation group were eligible for this study. In multivariate analysis of development group, age, carbohydrate antigen 19-9 (CA19-9), carbohydrate antigen 125 (CA125), cytoreductive surgery (CRS), hyperthermic intraperitoneal chemotherapy (HIPEC), and chemotherapy were independent variables for OS, based on which the nomogram was built. The C-index of the nomogram in the development and validation group was 0.701 (95% Cl, 0.666-0.736) and 0.716 (95% Cl, 0.622-0.810); demonstrating good discriminative ability. The calibration plots showed satisfactory consistency between actual observation and nomogram-predicted OS probabilities in the development and external validation group. The nomogram showed good predictive accuracy for 1-, 2-, and 3-year OS rates in both groups with AUC >0.70. An online dynamic webserver was also developed for increasing the ease of the nomogram.

CONCLUSIONS

We developed and validated a predictive nomogram with good discriminative and high accuracy to predict the OS in CRC patients with S-PM.

摘要

目的

同步性腹膜转移(S-PM)被认为是结直肠癌(CRC)的一个不良预后因素,目前尚无用于预测这些患者生存情况的列线图。在本研究中,我们旨在利用多中心数据确定与CRC的S-PM相关的因素,以构建一个预测这些患者总生存期(OS)的列线图。

方法

纳入2007年9月至2017年6月期间来自两个医疗中心的患有S-PM的CRC患者。采用多因素分析确定与用于预测开发组1年、2年和3年OS率的列线图相关的OS独立因素。计算一致性指数(C指数)、校准图、具有曲线下面积(AUC)的相对操作特征(ROC)曲线,以评估列线图在开发组和外部验证组中的性能。

结果

开发组中有277例患有S-PM的CRC患者,验证组中有68例患者符合本研究条件。在开发组的多因素分析中,年龄、糖类抗原19-9(CA19-9)、糖类抗原125(CA125)、细胞减灭术(CRS)、腹腔热灌注化疗(HIPEC)和化疗是OS的独立变量,并据此构建了列线图。开发组和验证组中列线图的C指数分别为0.701(95%CI,0.666-0.736)和0.716(95%CI,0.622-0.810),表明具有良好的辨别能力。校准图显示在开发组和外部验证组中实际观察结果与列线图预测的OS概率之间具有令人满意的一致性。列线图在两组中对1年、2年和3年OS率均显示出良好的预测准确性,AUC>0.70。还开发了一个在线动态网络服务器,以提高列线图的易用性。

结论

我们开发并验证了一个具有良好辨别能力和高准确性的预测列线图,用于预测患有S-PM的CRC患者的OS。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92f6/8281961/9f1702630be3/fonc-11-615321-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92f6/8281961/24fb9a145422/fonc-11-615321-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92f6/8281961/ee7c2416e7ab/fonc-11-615321-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92f6/8281961/4da4f20aefb7/fonc-11-615321-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92f6/8281961/9f1702630be3/fonc-11-615321-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92f6/8281961/24fb9a145422/fonc-11-615321-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92f6/8281961/ee7c2416e7ab/fonc-11-615321-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92f6/8281961/4da4f20aefb7/fonc-11-615321-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92f6/8281961/9f1702630be3/fonc-11-615321-g004.jpg

相似文献

1
Development and Validation of a Prognostic Nomogram for Colorectal Cancer Patients With Synchronous Peritoneal Metastasis.同步性腹膜转移结直肠癌患者预后列线图的开发与验证
Front Oncol. 2021 Jul 1;11:615321. doi: 10.3389/fonc.2021.615321. eCollection 2021.
2
Development and Validation of a Novel Prognostic Nomogram Combined With Desmoplastic Reaction for Synchronous Colorectal Peritoneal Metastasis.一种结合促纤维增生性反应的新型同步结直肠癌腹膜转移预后列线图的开发与验证
Front Oncol. 2022 Mar 11;12:826830. doi: 10.3389/fonc.2022.826830. eCollection 2022.
3
Effect of mutation on the prognosis for patients with colorectal cancer undergoing cytoreductive surgery for synchronous peritoneal metastasis.突变对接受同步腹膜转移细胞减灭术的结直肠癌患者预后的影响。
Gastroenterol Rep (Oxf). 2023 Oct 24;11:goad061. doi: 10.1093/gastro/goad061. eCollection 2023.
4
Development and validation of a prognostic nomogram for colorectal cancer after surgery.一种用于结直肠癌术后的预后列线图的开发与验证
World J Clin Cases. 2021 Jul 26;9(21):5860-5872. doi: 10.12998/wjcc.v9.i21.5860.
5
Peritoneal cancer index (PCI) based patient selecting strategy for complete cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy in gastric cancer with peritoneal metastasis: A single-center retrospective analysis of 125 patients.基于腹膜癌指数(PCI)的患者选择策略用于胃癌伴腹膜转移行完全细胞减灭术加腹腔热灌注化疗:一项单中心回顾性分析 125 例患者。
Eur J Surg Oncol. 2021 Jun;47(6):1411-1419. doi: 10.1016/j.ejso.2020.11.139. Epub 2020 Dec 1.
6
Development and validation of a nomogram for predicting metachronous peritoneal metastasis in colorectal cancer: A retrospective study.预测结直肠癌异时性腹膜转移列线图的开发与验证:一项回顾性研究
World J Gastrointest Oncol. 2023 Jan 15;15(1):112-127. doi: 10.4251/wjgo.v15.i1.112.
7
Impact of preoperative inflammatory and nutritional markers on the prognosis of patients with peritoneal metastasis of colorectal cancer.术前炎症和营养指标对结直肠癌腹膜转移患者预后的影响。
World J Gastrointest Oncol. 2024 Sep 15;16(9):3865-3874. doi: 10.4251/wjgo.v16.i9.3865.
8
Nomogram for predicting the overall survival of underweight patients with colorectal cancer: a clinical study.预测结直肠癌消瘦患者总体生存率的列线图:一项临床研究。
BMC Gastroenterol. 2023 Feb 13;23(1):39. doi: 10.1186/s12876-023-02669-8.
9
Development and validation of a prognostic nomogram for 2018 FIGO stages IB1, IB2, and IIA1 cervical cancer: a large multicenter study.2018年国际妇产科联盟(FIGO)IB1、IB2和IIA1期宫颈癌预后列线图的开发与验证:一项大型多中心研究
Ann Transl Med. 2022 Jan;10(2):121. doi: 10.21037/atm-21-6367.
10
Survival outcome and prognostic factors for colorectal cancer with synchronous bone metastasis: a population-based study.结直肠癌合并骨转移患者的生存结局和预后因素:一项基于人群的研究。
Clin Exp Metastasis. 2021 Feb;38(1):89-95. doi: 10.1007/s10585-020-10069-5. Epub 2021 Jan 9.

引用本文的文献

1
Development and Validation of Platelet-Index Based Colorectal Cancer Survival Prognostic Nomogram.基于血小板指数的结直肠癌生存预后列线图的开发与验证
Asian Pac J Cancer Prev. 2025 Apr 1;26(4):1365-1370. doi: 10.31557/APJCP.2025.26.4.1365.
2
Construction of a nomogram-based risk prediction model for depressive symptoms in middle-aged and young breast cancer patients.基于列线图的中青年乳腺癌患者抑郁症状风险预测模型的构建
World J Clin Oncol. 2025 Apr 24;16(4):102208. doi: 10.5306/wjco.v16.i4.102208.
3
Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in the Management of Colorectal Cancer with Peritoneal Metastasis: A Single-Center Cohort Study.

本文引用的文献

1
Germline mutational profile of Chinese patients under 70 years old with colorectal cancer.中国 70 岁以下结直肠癌患者的种系突变特征。
Cancer Commun (Lond). 2020 Nov;40(11):620-632. doi: 10.1002/cac2.12093. Epub 2020 Sep 10.
2
The Validity of Registered Synchronous Peritoneal Metastases from Colorectal Cancer in the Danish Medical Registries.丹麦医学登记处中结直肠癌登记同步性腹膜转移的有效性
Clin Epidemiol. 2020 Mar 27;12:333-343. doi: 10.2147/CLEP.S238193. eCollection 2020.
3
Global Burden of 5 Major Types of Gastrointestinal Cancer.
细胞减灭术和腹腔热灌注化疗治疗结直肠癌伴腹膜转移:单中心队列研究。
Medicina (Kaunas). 2024 Jun 27;60(7):1058. doi: 10.3390/medicina60071058.
4
A prediction nomogram for perineural invasion in colorectal cancer patients: a retrospective study.预测结直肠癌患者神经周围侵犯的列线图:一项回顾性研究。
BMC Surg. 2024 Mar 5;24(1):80. doi: 10.1186/s12893-024-02364-9.
5
Cytoreductive surgery for synchronous and metachronous colorectal peritoneal dissemination: Japanese P classification and peritoneal cancer index.同步和异时性结直肠癌腹膜播散的细胞减灭术:日本P分类和腹膜癌指数
Ann Gastroenterol Surg. 2023 Jul 19;8(1):88-97. doi: 10.1002/ags3.12721. eCollection 2024 Jan.
6
Prognostic value of normal levels of preoperative tumor markers in colorectal cancer.术前肿瘤标志物正常水平对结直肠癌的预后价值。
Sci Rep. 2023 Dec 20;13(1):22830. doi: 10.1038/s41598-023-49832-5.
7
Effect of mutation on the prognosis for patients with colorectal cancer undergoing cytoreductive surgery for synchronous peritoneal metastasis.突变对接受同步腹膜转移细胞减灭术的结直肠癌患者预后的影响。
Gastroenterol Rep (Oxf). 2023 Oct 24;11:goad061. doi: 10.1093/gastro/goad061. eCollection 2023.
8
Development and validation of a nomogram for predicting metachronous peritoneal metastasis in colorectal cancer: A retrospective study.预测结直肠癌异时性腹膜转移列线图的开发与验证:一项回顾性研究
World J Gastrointest Oncol. 2023 Jan 15;15(1):112-127. doi: 10.4251/wjgo.v15.i1.112.
9
Mid-Arm Muscle Circumference or Body Weight-Standardized Hand Grip Strength in the GLIM Superiorly Predicts Survival in Chinese Colorectal Cancer Patients.上臂肌围或体重标准化握力在 GLIM 中可更好地预测中国结直肠癌患者的生存情况。
Nutrients. 2022 Dec 5;14(23):5166. doi: 10.3390/nu14235166.
10
Lobaplatin hyperthermic intraperitoneal chemotherapy plus cytoreduction and rechallenge using cetuximab for wild-type RAS peritoneal metastatic colon cancer: a case report and literature review.洛铂腹腔热灌注化疗联合细胞减灭术及西妥昔单抗再挑战治疗野生型 RAS 腹膜转移性结直肠癌 1 例报告并文献复习
BMC Gastroenterol. 2022 Feb 14;22(1):65. doi: 10.1186/s12876-022-02109-z.
全球 5 大常见胃肠道癌症负担
Gastroenterology. 2020 Jul;159(1):335-349.e15. doi: 10.1053/j.gastro.2020.02.068. Epub 2020 Apr 2.
4
Synchronous and Metachronous Peritoneal Metastases in Patients with Left-Sided Obstructive Colon Cancer.左侧梗阻性结肠癌患者的同时性和异时性腹膜转移。
Ann Surg Oncol. 2020 Aug;27(8):2762-2773. doi: 10.1245/s10434-020-08327-7. Epub 2020 Mar 13.
5
Colorectal cancer statistics, 2020.2020 年结直肠癌统计数据。
CA Cancer J Clin. 2020 May;70(3):145-164. doi: 10.3322/caac.21601. Epub 2020 Mar 5.
6
Colorectal peritoneal metastases: pathogenesis, diagnosis and treatment options - an evidence-based update.结直肠腹膜转移:发病机制、诊断及治疗选择——基于证据的最新进展
ANZ J Surg. 2020 Sep;90(9):1592-1597. doi: 10.1111/ans.15796. Epub 2020 Mar 4.
7
A real-world, population-based study of the outcomes of patients with metastatic colorectal cancer to the peritoneum treated with or without cytoreductive surgery.一项真实世界、基于人群的研究,旨在评估接受或不接受细胞减灭性手术治疗腹膜转移结直肠癌患者的结局。
Int J Colorectal Dis. 2020 Apr;35(4):719-725. doi: 10.1007/s00384-020-03525-x. Epub 2020 Feb 14.
8
Role of diagnostic laparoscopy in patients with suspicion of colorectal peritoneal metastases to evaluate suitability for cytoreductive surgery with hyperthermic intraperitoneal chemotherapy.诊断性腹腔镜检查在怀疑结直肠腹膜转移患者中评估行细胞减灭术联合腹腔内热化疗的适用性。
BJS Open. 2019 Sep 18;3(6):812-821. doi: 10.1002/bjs5.50193. eCollection 2019 Dec.
9
Postoperative chemotherapy is associated with prognosis of stage IV colorectal cancer treated with preoperative chemotherapy/chemoradiotherapy and curative resection.术后化疗与术前化疗/放化疗和根治性切除治疗的 IV 期结直肠癌的预后相关。
Int J Colorectal Dis. 2020 Jan;35(1):177-180. doi: 10.1007/s00384-019-03461-5. Epub 2019 Dec 5.
10
CRS and HIPEC in patients with peritoneal metastasis secondary to colorectal cancer: The small-bowel PCI score as a predictor of survival.结直肠癌继发腹膜转移患者的CRS和HIPEC:小肠PCI评分作为生存预测指标
Pleura Peritoneum. 2019 Oct 30;4(4):20190018. doi: 10.1515/pp-2019-0018. eCollection 2019 Dec 1.